Mechanisms of Pathogenesis of Arterial Thrombosis: Potential Sites of Inhibition by Therapeutic Compounds

Buchanan, Michael R.

doi:10.1055/s-2007-1002753

Cited by 8 publications

(3 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…12 This interaction may be mediated, in part, by production of prostaglandin intermediates of the linoleic acid pathway 13 and therefore be susceptible to inhibition by drugs with selective action on the lipoxygenase enzyme (summarized in this issue of Seminars by Buchanan). 14…”

Section: Tumor Cell-host Cell Interactions and Activation Of Hemostatmentioning

confidence: 99%

“…Falanga and Gordon 13 have reported recently the isolation and characterization of CP from the rabbit V2 carcinoma. Although not unique to malignant tissue, 14,15 this interesting protease may play a role in the deposition of fibrin within tumors. Many tumor cells also appear to contain TF, which is a more potent PCA than CP, as judged by relative catalytic rates of Factor X conversion.…”

Section: Tumor-associated Procoagulantsmentioning

confidence: 99%

See 1 more Smart Citation

Antimetastatic Agents. I. Role of Cellular Procoagulants in the Pathogenesis of Fibrin Deposition in Cancer and the Use of Anticoagulants and/or Antiplatelet Drugs in Cancer Treatment

Rickles

Hancock²,

Edwards³

et al. 1988

Semin Thromb Hemost

View full text Add to dashboard Cite

Section: Tumor Cell-host Cell Interactions and Activation Of Hemostatmentioning

confidence: 99%

Section: Tumor-associated Procoagulantsmentioning

confidence: 99%

Antimetastatic Agents. I. Role of Cellular Procoagulants in the Pathogenesis of Fibrin Deposition in Cancer and the Use of Anticoagulants and/or Antiplatelet Drugs in Cancer Treatment

Rickles

Hancock²,

Edwards³

et al. 1988

Semin Thromb Hemost

View full text Add to dashboard Cite

“…Consequently, platelets will not initially adhere to the base m ent m em brane following endothelial cell denudation . W hen the production of 13-H O D E is inhibited or when d eeper layers in the vessel wall are exposed, platelets will not only adhere but also aggregate (Buchanan, 1988).…”

Section: A Ntithrom Botic Propertiesmentioning

confidence: 99%

Thromboembolic reaction following vessel wall injury in arterioles and venules

Egbrink¹

View full text Add to dashboard Cite

People interested in the research are advised to contact the author for the final version of the publication, or visit the DOI to the publisher's website.• The final author version and the galley proof are versions of the publication after peer review.• The final published version features the final layout of the paper including the volume, issue and page numbers. Link to publication General rightsCopyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal.If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the "Taverne" license above, please follow below link for the End User Agreement:

show abstract

Eicosanoid Metabolism and Endothelial Cell Adhesion Molecule Expression: Effects on Platelet/Vessel Wall Interactions

et al. 1991

View full text Add to dashboard Cite

Mechanisms of Pathogenesis of Arterial Thrombosis: Potential Sites of Inhibition by Therapeutic Compounds

Cited by 8 publications

References 35 publications

Antimetastatic Agents. I. Role of Cellular Procoagulants in the Pathogenesis of Fibrin Deposition in Cancer and the Use of Anticoagulants and/or Antiplatelet Drugs in Cancer Treatment

Antimetastatic Agents. I. Role of Cellular Procoagulants in the Pathogenesis of Fibrin Deposition in Cancer and the Use of Anticoagulants and/or Antiplatelet Drugs in Cancer Treatment

Thromboembolic reaction following vessel wall injury in arterioles and venules

Eicosanoid Metabolism and Endothelial Cell Adhesion Molecule Expression: Effects on Platelet/Vessel Wall Interactions

Contact Info

Product

Resources

About